KatherineKurnitKatherine Kurnit41.7886000000000087.598699999999993851Kurnit, Katherine+1 (773) 7021220Assistant Professorprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonJosephineKimJosephine Kim41.7886000000000087.598699999999993551Kim, JosephineAssistant ProfessorJenniferBennettJennifer Bennett41.7886000000000087.598699999999993688Bennett, JenniferAssociate ProfessorObstetrics and GynecologyMedicine-Hematology/OncologyChicago60637IL6.02150.0118002152research areas1.4130.051442215coauthor of99.755111.235160similar to1140selected publicationsAuthorship 1323121Authorship 1323181Authorship 1323211Authorship 1323222Authorship 1323251Authorship 1323151Authorship 1323321Authorship 1323162Authorship 1323171Authorship 1323202Authorship 1323231Authorship 1323261Authorship 132329130231353Colombo I, Kurnit KC, Westin SN, Oza AMAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingMoving From Mutation to Actionability. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:495-503.Am Soc Clin Oncol Educ Book2018-05-23T00:00:002018Moving From Mutation to Actionability.30913308Kurnit KC, Westin SN, Coleman RLCancerMicrosatellite instability in endometrial cancer: New purpose for an old test. Cancer. 2019 07 01; 125(13):2154-2163.Cancer2019-03-26T00:00:002019Microsatellite instability in endometrial cancer: New purpose for an old test.29092956Kurnit KC, Bailey AM, Zeng J, Johnson AM, Shufean MA, Brusco L, Litzenburger BC, Sánchez NS, Khotskaya YB, Holla V, Simpson A, Mills GB, Mendelsohn J, Bernstam E, Shaw K, Meric-Bernstam FCancer research"Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource. Cancer Res. 2017 11 01; 77(21):e123-e126.Cancer Res2017-11-01T00:00:002017"Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource.26160712Kurnit KC, Ward KK, McHale MT, Saenz CC, Plaxe SCGynecologic oncologyIncreased prevalence of comorbid conditions in women with uterine cancer. Gynecol Oncol. 2015 Sep; 138(3):731-4.Gynecol Oncol2015-07-06T00:00:002015Increased prevalence of comorbid conditions in women with uterine cancer.30414738Kurnit KC, Previs RA, Soliman PT, Westin SN, Klopp AH, Fellman BM, Lu KH, Ramondetta LM, Fleming NDGynecologic oncologyPrognostic factors impacting survival in early stage uterine carcinosarcoma. Gynecol Oncol. 2019 01; 152(1):31-37.Gynecol Oncol2018-11-08T00:00:002018Prognostic factors impacting survival in early stage uterine carcinosarcoma.30535808Kurnit KC, Coleman RL, Westin SNCurrent treatment options in oncologyUsing PARP Inhibitors in the Treatment of Patients With Ovarian Cancer. Curr Treat Options Oncol. 2018 11 15; 19(12):1.Curr Treat Options Oncol2018-11-15T00:00:002018Using PARP Inhibitors in the Treatment of Patients With Ovarian Cancer.29795437Kim G, Kurnit KC, Djordjevic B, Singh C, Munsell MF, Wang WL, Lazar AJ, Zhang W, Broaddus RModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncNuclear ß-catenin localization and mutation of the CTNNB1 gene: a context-dependent association. Mod Pathol. 2018 10; 31(10):1553-1559.Mod Pathol2018-05-24T00:00:002018Nuclear ß-catenin localization and mutation of the CTNNB1 gene: a context-dependent association.30291344Crumley S, Kurnit K, Hudgens C, Fellman B, Tetzlaff MT, Broaddus RModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncIdentification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes. Mod Pathol. 2019 03; 32(3):396-404.Mod Pathol2018-10-05T00:00:002018Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes.26540247Kurnit KC, Overcash RT, Ramos GA, LaCoursiere DYJournal of perinatology : official journal of the California Perinatal AssociationThe impact of inadequate gestational weight gain in obese diabetic women. J Perinatol. 2016 Feb; 36(2):86-9.J Perinatol2015-11-05T00:00:002015The impact of inadequate gestational weight gain in obese diabetic women.29420224Kurnit KC, Dumbrava EEI, Litzenburger B, Khotskaya YB, Johnson AM, Yap TA, Rodon J, Zeng J, Shufean MA, Bailey AM, Sánchez NS, Holla V, Mendelsohn J, Shaw KM, Bernstam EV, Mills GB, Meric-Bernstam FClinical cancer research : an official journal of the American Association for Cancer ResearchPrecision Oncology Decision Support: Current Approaches and Strategies for the Future. Clin Cancer Res. 2018 06 15; 24(12):2719-2731.Clin Cancer Res2018-02-02T00:00:002018Precision Oncology Decision Support: Current Approaches and Strategies for the Future.30230291Kurnit KC, Bean LM, Plaxe SC, Saenz CC, McHale MTThe Journal of reproductive medicineSquamous Cell Carcinoma of the Vulva Presenting as an Isolated Inguinal Lymph Node Metastasis: A Case Report. J Reprod Med. 2016 Nov-Dec; 61(11-12):612-14.J Reprod Med2016-11-01T00:00:002016Squamous Cell Carcinoma of the Vulva Presenting as an Isolated Inguinal Lymph Node Metastasis: A Case Report.28281553Kurnit KC, Kim GN, Fellman BM, Urbauer DL, Mills GB, Zhang W, Broaddus RRModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncCTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence. Mod Pathol. 2017 07; 30(7):1032-1041.Mod Pathol2017-03-10T00:00:002017CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.31283416Kurnit KC, Lu KH, Westin SNJournal of oncology practiceRapidly Changing Landscape of Fallopian Tube Carcinoma. J Oncol Pract. 2019 07; 15(7):383-384.J Oncol Pract2019-07-08T00:00:002019Rapidly Changing Landscape of Fallopian Tube Carcinoma.Authorship 132489331427143Matsuo K, Cripe JC, Kurnit KC, Kaneda M, Garneau AS, Glaser GE, Nizam A, Schillinger RM, Kuznicki ML, Yabuno A, Yanai S, Garofalo DM, Suzuki J, St Laurent JD, Yen TT, Liu AY, Shida M, Kakuda M, Oishi T, Nishio S, Marcus JZ, Adachi S, Kurokawa T, Ross MS, Horowitz MP, Johnson MS, Kim MK, Melamed A, Machado KK, Yoshihara K, Yoshida Y, Enomoto T, Ushijima K, Satoh S, Ueda Y, Mikami M, Rimel BJ, Stone RL, Growdon WB, Okamoto A, Guntupalli SR, Hasegawa K, Shahzad MMK, Im DD, Frimer M, Gostout BS, Ueland FR, Nagao S, Soliman PT, Thaker PH, Wright JD, Roman LDGynecologic oncologyRecurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer. Gynecol Oncol. 2019 10; 155(1):39-50.Gynecol Oncol2019-08-16T00:00:002019Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.D010051Disorders1667380.613506Ovarian NeoplasmsAuthorship 134190131698370Kurnit KC, Sinno AK, Fellman BM, Varghese A, Stone R, Sood AK, Gershenson DM, Schmeler KM, Malpica A, Fader AN, Frumovitz MObstetrics and gynecologyEffects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma. Obstet Gynecol. 2019 Nov 04.Obstet Gynecol2019-11-04T00:00:002019Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma.Authorship 134469131764736Kurnit KC, Sinno AK, Fellman BM, Varghese A, Stone R, Sood AK, Gershenson DM, Schmeler KM, Malpica A, Fader AN, Frumovitz MObstetrics and gynecologyEffects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma. Obstet Gynecol. 2019 12; 134(6):1253-1259.Obstet Gynecol2019-12-01T00:00:002019Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma.D014594Disorders602250.739689Uterine NeoplasmsAuthorship 137277132376741Kurnit KC, Westin SNInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietySlow and steady wins the race: precision medicine for low risk endometrial cancer. Int J Gynecol Cancer. 2020 06; 30(6):724-725.Int J Gynecol Cancer2020-05-05T00:00:002020Slow and steady wins the race: precision medicine for low risk endometrial cancer.Authorship 137836132450190Kurnit KC, Avila M, Hinchcliff EM, Coleman RL, Westin SNPharmacology & therapeuticsPARP inhibition in the ovarian cancer patient: Current approvals and future directions. Pharmacol Ther. 2020 09; 213:107588.Pharmacol Ther2020-05-23T00:00:002020PARP inhibition in the ovarian cancer patient: Current approvals and future directions.Authorship 139036132641238Kurnit KC, Reid P, Moroney JW, Fleming GFGynecologic oncologyImmune checkpoint inhibitors in women with gynecologic cancers: Practical considerations. Gynecol Oncol. 2020 09; 158(3):531-537.Gynecol Oncol2020-07-05T00:00:002020Immune checkpoint inhibitors in women with gynecologic cancers: Practical considerations.AymanAl-HendyAyman Al-Hendy41.7886000000000087.598699999999993954Al-Hendy, AymanProfessorAuthorship 142597133278287Kurnit KC, Fleming GF, Lengyel EObstetrics and gynecologyUpdates and New Options in Advanced Epithelial Ovarian Cancer Treatment. Obstet Gynecol. 2021 01 01; 137(1):108-121.Obstet Gynecol2021-01-01T00:00:002021Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment.Medicine-Hematology and OncologyObstetrics and Gynecology-Gynecologic OncologyAuthorship 144570133609609Kurnit KC, Draisey A, Kazen RC, Chung C, Phan LH, Harvey JB, Feng J, Xie S, Broaddus RR, Bowser JLCancer lettersLoss of CD73 shifts transforming growth factor-ß1 (TGF-ß1) from tumor suppressor to promoter in endometrial cancer. Cancer Lett. 2021 05 01; 505:75-86.Cancer Lett2021-02-17T00:00:002021Loss of CD73 shifts transforming growth factor-ß1 (TGF-ß1) from tumor suppressor to promoter in endometrial cancer.AdekunleOdunsiAdekunle Odunsi41.7886000000000087.598699999999994008Odunsi, AdekunleProfessorTakemasaTsujiTakemasa Tsuji41.7886000000000087.598699999999994020Tsuji, TakemasaResearch Associate ProfessorAuthorship 145651833833085Jani I, Lastra RR, Brito KS, Liao C, Lazo I, Lee NK, Yamada SD, Kurnit KCInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyChemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy. Int J Gynecol Cancer. 2021 06; 31(6):852-858.Int J Gynecol Cancer2021-04-08T00:00:002021Chemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy.Authorship 146384433959831Goldberg EM, Berger Y, Sood D, Kurnit KC, Kim JS, Lee NK, Yamada SD, Turaga KK, Eng OSAnnals of surgical oncologyDifferences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer. Ann Surg Oncol. 2021 Nov; 28(12):7795-7806.Ann Surg Oncol2021-05-06T00:00:002021Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer.33978887Goldberg EM, Berger Y, Sood D, Kurnit KC, Kim JS, Lee NK, Yamada SD, Turaga KK, Eng OSAnnals of surgical oncologyASO Visual Abstract: Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer. Ann Surg Oncol. 2021 12; 28(Suppl 3):430-431.Ann Surg Oncol2021-12-01T00:00:002021ASO Visual Abstract: Differences in Sociodemographic Disparities in Patients Undergoing Surgery for Advanced Colorectal and Ovarian Cancer.Authorship 1465114D016889Disorders641910.802339Endometrial NeoplasmsD009364Disorders33613050.61985Neoplasm Recurrence, LocalAuthorship 146993334103196Ackroyd SA, Huang ES, Kurnit KC, Lee NKGynecologic oncologyPembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis. Gynecol Oncol. 2021 08; 162(2):249-255.Gynecol Oncol2021-06-06T00:00:002021Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis.Authorship 148332234321288Broaddus RR, Kurnit KCInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyLow grade endometrioid endometrial cancer: complexities beyond p53abn. Int J Gynecol Cancer. 2021 09; 31(9):1312.Int J Gynecol Cancer2021-07-28T00:00:002021Low grade endometrioid endometrial cancer: complexities beyond p53abn.Authorship 148783534368414Wu M, Bennett JA, Reid P, Fleming GF, Kurnit KCGynecologic oncology reportsSuccessful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab. Gynecol Oncol Rep. 2021 Aug; 37:100837.Gynecol Oncol Rep2021-07-22T00:00:002021Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab.D018269Disorders23430.94136Carcinoma, EndometrioidAuthorship 152278635059489Asom AS, Lastra RR, Hasan Y, Weinberg L, Fleming GF, Kurnit KCGynecologic oncology reportsSmall cell carcinoma of the ovary, pulmonary type: A role for adjuvant radiotherapy after carboplatin and etoposide? Gynecol Oncol Rep. 2022 Feb; 39:100925.Gynecol Oncol Rep2022-01-07T00:00:002022Small cell carcinoma of the ovary, pulmonary type: A role for adjuvant radiotherapy after carboplatin and etoposide?Authorship 152406335077576Bennett JA, Fleming GF, Kurnit KC, Mills KA, vanWeelden WJCA: a cancer journal for cliniciansTumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancer. CA Cancer J Clin. 2022 03; 72(2):102-111.CA Cancer J Clin2022-01-25T00:00:002022Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancer.Authorship 153172535201895Javellana M, Hlubocky FJ, Somasegar S, Sorkin M, Kurnit KC, Jani I, Stock E, Mills K, Lengyel E, Lee NKJCO oncology practiceResilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer. JCO Oncol Pract. 2022 06; 18(6):e948-e957.JCO Oncol Pract2022-02-24T00:00:002022Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer.Authorship 154401135483739Kurnit KC, Fellman BM, Mills GB, Bowser JL, Xie S, Broaddus RRInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyAdjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival. Int J Gynecol Cancer. 2022 07 04; 32(7):869-874.Int J Gynecol Cancer2022-07-04T00:00:002022Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival.Authorship 154536135519002Kurnit KC, Steiner M, Lastra RR, Weroha SJ, Cursio J, Lengyel E, Fleming GF, Conzen SDGynecologic oncology reportsHigh glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas. Gynecol Oncol Rep. 2022 Jun; 41:100987.Gynecol Oncol Rep2022-04-27T00:00:002022High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas.Authorship 1595653Authorship 1597971Authorship 159780136229081Kurnit KC, Frumovitz MInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPrimary mucinous ovarian cancer: options for surgery and chemotherapy. Int J Gynecol Cancer. 2022 Oct 13.Int J Gynecol Cancer2022-10-13T00:00:002022Primary mucinous ovarian cancer: options for surgery and chemotherapy.36139624Nakad Borrego S, Lengyel E, Kurnit KCCancersMolecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment. Cancers (Basel). 2022 Sep 14; 14(18).Cancers (Basel)2022-09-14T00:00:002022Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment.36243601Kurnit KC, Nobre SP, Fellman BM, Iglesias DA, Lindemann K, Jhingran A, Eriksson AGZ, Ataseven B, Glaser GE, Mueller JJ, Westin SN, Soliman PTGynecologic oncologyAdjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study. Gynecol Oncol. 2022 Dec; 167(3):452-457.Gynecol Oncol2022-10-13T00:00:002022Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study.https://obgyn.uchicago.edu/page/section-gynecologic-oncologyGynecologic Oncology Section - Univ. of Chicagohttps://obgyn.uchicago.edu/Univ. of Chicago OB&GYNhttp://obg.bsd.uchicago.edu/FacultyResearch/lengyellab.htmOvarian Cancer Laboratory in Chicagohttps://www.uchicagomedicine.org/find-a-physician/physician/ernst-lengyelClinical Profilehttps://www.uchicagomedicine.org/conditions-services/obgyn/specialtyOB&GYN Clinical Patient informationAuthorship 162082737154098Leo J, Dondossola E, Basham KJ, Wilson NR, Alhalabi O, Gao J, Kurnit KC, White MG, McQuade JL, Westin SN, Wellberg EA, Frigo DEEndocrinologyStranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer. Endocrinology. 2023 04 17; 164(6).Endocrinology2023-04-17T00:00:002023Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.Authorship 16364914Authorship 163895237295818Disis ML, Adams SF, Bajpai J, Butler MO, Curiel T, Dodt SA, Doherty L, Emens LA, Friedman CF, Gatti-Mays M, Geller MA, Jazaeri A, John VS, Kurnit KC, Liao JB, Mahdi H, Mills A, Zsiros E, Odunsi KJournal for immunotherapy of cancerSociety for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer. J Immunother Cancer. 2023 06; 11(6).J Immunother Cancer2023-06-01T00:00:002023Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.37380216Nakad Borrego S, Kurnit K, Turner LJ, Broaddus RRInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyContext-dependent environmental associations with endometrial cancer histotype and genotype. Int J Gynecol Cancer. 2023 08 07; 33(8):1215-1221.Int J Gynecol Cancer2023-08-07T00:00:002023Context-dependent environmental associations with endometrial cancer histotype and genotype.MedicinePathologyUniversity of ChicagoHanCunHan Cun41.7886000000000087.598699999999994429Cun, HanAssistant ProfessorGiniFleming0GRlDqwcF+v5hHlsaUXv9Gq0+s+oGini Fleming41.78927490000000-87.601250000000001804Fleming, GiniProfessorErnst RobertLengyel0m5sBaYMHOD5hHlsaUXv9Gq0+s+oErnst Robert Lengyel41.78927490000000-87.601250000000001942Lengyel, Ernst RobertProfessorRichardSchilskyRichard Schilsky41.78927490000000-87.601250000000002119Schilsky, RichardProfessor EmeritusSuzanneConzenSuzanne D. Conzen41.78927490000000-87.60125000000000599Conzen, SuzanneProfessorNitaLeeNita Lee41.78927490000000-87.6012500000000095Lee, NitaAssociate ProfessorAuthorship 1687722438088182Cucinella G, Schivardi G, Zhou XC, AlHilli M, Wallace S, Wohlmuth C, Baiocchi G, Tokgozoglu N, Raspagliesi F, Buda A, Zanagnolo V, Zapardiel I, Jagasia N, Giuntoli R, Glickman A, Peiretti M, Lanner M, Chacon E, Di Guilmi J, Pereira A, Laas-Faron E, Fishman A, Nitschmann CC, Kurnit K, Moriarty K, Joehlin-Price A, Lees B, Covens A, De Brot L, Taskiran C, Bogani G, Landoni F, Grassi T, Paniga C, Multinu F, De Vitis LA, Hernández A, Mastroyannis S, Ghoniem K, Chiantera V, Shahi M, Fought AJ, McGree M, Mariani A, Glaser GInternational journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPrognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study. Int J Gynecol Cancer. 2023 Dec 07.Int J Gynecol Cancer2023-12-07T00:00:002023Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study.38449895Peerenboom R, Wang S, Morgan R, Sankary S, Yassan L, Kurnit K, Posner MCClinical case reportsMüllerian-type carcinosarcoma arising in gastric endometriosis: Case report and review of the literature. Clin Case Rep. 2024 Mar; 12(3):e8604.Clin Case Rep2024-03-05T00:00:002024Müllerian-type carcinosarcoma arising in gastric endometriosis: Case report and review of the literature.Authorship 1708016SudarshanSharmaSudarshan Sharma41.7886000000000087.598699999999994532Sharma, SudarshanClinical Associatetrue1Professor EmeritusProfessor Emeritustrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Research Associate ProfessorResearch Associate Professortrue1Clinical AssociateClinical Associatetrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professor1010RicardoLastraRicardo Lastra0.000000000000000.000000000000003226Lastra, RicardoAssociate Professor